UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$3.78B |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$718M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$218M |
| 4 |
Union Pacific
UNP
|
+$210M |
| 5 |
Alcon
ALC
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$820M |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$604M |
| 3 |
Apple
AAPL
|
+$598M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$524M |
| 5 |
TSMC
TSM
|
+$324M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.29% |
| 2 | Financials | 8.09% |
| 3 | Healthcare | 6.75% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JBGS
3626
JBG SMITH
JBGS
$708M
| $1.66M | ﹤0.01% |
110,084
-32,245
| -23% | -$572K |
|
3627
Denison Mines
DNN
$2.91B
| $1.66M | ﹤0.01% |
1,519,419
+152,725
| +11% | +$189K |
|
3628
Aehr Test Systems
AEHR
$3.36B
| $1.66M | ﹤0.01% |
53,383
+21,544
| +68% | +$694K |
|
|
ICPT
3629
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.65M | ﹤0.01% |
123,148
-83,170
| -40% | -$1.44M |
|
3630
MidCap Financial Investment
MFIC
$804M
| $1.65M | ﹤0.01% |
144,971
+33,522
| +30% | +$402K |
|
3631
Azenta
AZTA
$1.48B
| $1.65M | ﹤0.01% |
36,988
-18,217
| -33% | -$902K |
|
3632
Parsons
PSN
$5.08B
| $1.65M | ﹤0.01% |
36,876
+10,795
| +41% | +$474K |
|
|
NTST
3633
NETSTREIT Corp
NTST
$2.1B
| $1.64M | ﹤0.01% |
89,718
+47,093
| +110% | +$909K |
|
3634
PUT
Brunswick
BC
$5.28B
| $1.64M | ﹤0.01% |
20,000
+5,000
| +33% | +$413K |
|
3635
Enpro
NPO
$7.05B
| $1.64M | ﹤0.01% |
15,777
+1,677
| +12% | +$184K |
|
3636
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$912M
| $1.64M | ﹤0.01% |
154,915
-92,687
| -37% | -$977K |
|
3637
KT
KT
$8.81B
| $1.63M | ﹤0.01% |
144,170
-9,629
| -6% | -$123K |
|
3638
International Bancshares
IBOC
$4.57B
| $1.63M | ﹤0.01% |
38,177
+9,911
| +35% | +$451K |
|
3639
Beam Therapeutics
BEAM
$2.84B
| $1.63M | ﹤0.01% |
53,285
-85,420
| -62% | -$3.37M |
|
3640
CALL
Amylyx Pharmaceuticals
AMLX
$2.54B
| $1.63M | ﹤0.01% |
+55,600
| New | +$1.93M |
|
3641
Gorman-Rupp
GRC
$2.21B
| $1.63M | ﹤0.01% |
65,222
+6,251
| +11% | +$166K |
|
|
NARI
3642
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $1.63M | ﹤0.01% |
26,380
+8,041
| +44% | +$482K |
|
3643
Guidewire Software
GWRE
$14.2B
| $1.63M | ﹤0.01% |
19,835
+2,936
| +17% | +$213K |
|
3644
BlackRock Income Trust
BKT
$341M
| $1.63M | ﹤0.01% |
129,208
-18,430
| -12% | -$236K |
|
3645
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.96B
| $1.62M | ﹤0.01% |
88,473
-5,210
| -6% | -$96.3K |
|
3646
Protolabs
PRLB
$2.13B
| $1.62M | ﹤0.01% |
48,957
+9,863
| +25% | +$305K |
|
3647
PUT
Evolent Health
EVH
$444M
| $1.62M | ﹤0.01% |
50,000
| – | – |
|
3648
InterDigital
IDCC
$8.89B
| $1.62M | ﹤0.01% |
22,201
+2,463
| +12% | +$171K |
|
|
MCI
3649
Barings Corporate Investors
MCI
$345M
| $1.62M | ﹤0.01% |
114,335
-4,791
| -4% | -$67.9K |
|
|
ARNC
3650
DELISTED
Arconic Corporation
ARNC
| $1.62M | ﹤0.01% |
61,640
+45,446
| +281% | +$1.12M |
|
Similar funds
UBS Group's Q1 2023 Portfolio in Review
As of Q1 2023, UBS Group held 11,664 positions worth $274B, up 2.2% from $268B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group withdrew a net $10.4B in Q1 2023, closing 2,127 positions and reducing 4,260 holdings. Its most notable exit was LHC Group LLC, an estimated $49M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in First Trust Nasdaq Oil & Gas ETF worth $13.3M.
- UBS Group's largest Q1 2023 buy was First Trust Nasdaq Oil & Gas ETF: 493,205 shares worth $13.3M.
- UBS Group added most to UBS Group in Q1 2023, an estimated $3.78B increase.
- UBS Group's biggest Q1 2023 reduction was Microsoft, cutting an estimated $820M.
- UBS Group fully exited LHC Group LLC in Q1 2023, selling an estimated $49M.
- UBS Group's ten largest holdings make up 16% of its $274B portfolio in Q1 2023.
- UBS Group opened 983 new positions and closed 2,127 in Q1 2023.
- UBS Group's portfolio value rose 2.2% quarter-over-quarter to $274B.
Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.